Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.3M Health Care and Greystone Pharmaceuticals have entered into an exclusive, worldwide license agreement for wound care products using Greystone's patented polyhydrated ionogens technology, a proprietary formulation that aids in the management of hard-to-heal wounds.
Subscribe to our email newsletter
This is the second agreement between 3M Health Care and Greystone Pharmaceuticals. The first agreement provided 3M Health Care distribution rights in Canada and parts of Europe.
This new agreement broadens 3M Health Care’s rights to the US and most major countries in the world, starting with the introduction of 3M Tegaderm Matrix Dressing with polyhydrated ionogens (PHI) technology to the US market. In addition, 3M Health Care will be able to extend the PHI technology platform to other wound care products.
Bill Cruise, skin and wound care global business director of 3M Health Care, said: “This license agreement will enhance 3M Health Care’s rapidly growing advanced wound care business and builds on our reputation as a global leader in the treatment of chronic wounds.”